# Ovid Therapeutics (OVID) — Earnings

OVID · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/ovid/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2025 |
| Period end | Jun 30, 2025 |
| EPS actual | −$0.06 |
| EPS estimate | −$0.16 |
| EPS surprise | +62.00% |
| Revenue surprise | +6289.11% |
| Revenue | $6.3M |
| Revenue estimate | $98,167.00 |
| Reported | Aug 13, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1636651/000162828025040008/ovid-20250630.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2025 | Aug 13, 2025 | −$0.16 | −$0.06 | 62.00% | $98,167.00 | $6.3M |
| Q1 2025 | May 13, 2025 | −$0.14 | −$0.14 | -1.82% | $49,600.00 | $130,000.00 |
| Q4 2024 | Mar 11, 2025 | −$0.17 | −$0.13 | 22.94% | $190,375.00 | $76,000.00 |
| Q3 2024 | Nov 12, 2024 | −$0.21 | −$0.20 | 3.15% | $105,500.00 | $173,000.00 |
| Q2 2024 | Aug 13, 2024 | −$0.22 | $0.12 | 153.60% | $65,375.00 | $169,000.00 |
| Q1 2024 | May 14, 2024 | −$0.22 | −$0.17 | 23.94% | $52,075.00 | $148,000.00 |
| Q4 2023 | Mar 8, 2024 | −$0.05 | −$0.22 | -335.64% | $8.6M | $141,562.00 |
| Q3 2023 | Nov 3, 2023 | −$0.19 | −$0.16 | 13.70% | $45,833.00 | $108,972.00 |
| Q2 2023 | Aug 4, 2023 | −$0.20 | −$0.18 | 11.89% | $47,750.00 | $75,000.00 |
| Q1 2023 | May 5, 2023 | −$0.17 | −$0.19 | -10.98% | $18,767.00 | $66,160.00 |
| Q4 2022 | Mar 13, 2023 | −$0.17 | −$0.16 | 6.92% | — | $46,280.00 |
| Q3 2022 | Nov 8, 2022 | −$0.21 | −$0.17 | 20.63% | — | $11,102.00 |
| Q2 2022 | Aug 9, 2022 | −$0.25 | −$0.21 | 15.59% | — | — |
| Q1 2022 | May 10, 2022 | −$0.21 | −$0.23 | -11.00% | — | $1.4M |
| Q4 2021 | Mar 15, 2022 | −$0.16 | −$0.38 | -135.88% | — | — |
| Q3 2021 | Nov 10, 2021 | −$0.19 | −$0.17 | 10.05% | — | — |
| Q2 2021 | Aug 16, 2021 | −$0.16 | −$0.23 | -40.24% | — | — |
| Q1 2021 | May 13, 2021 | $1.45 | $2.53 | 74.66% | $100.5M | $208.4M |
| Q4 2020 | Mar 15, 2021 | −$0.31 | −$0.34 | -11.26% | $4.2M | $5.7M |
| Q3 2020 | Nov 12, 2020 | −$0.35 | −$0.28 | 20.09% | $100,000.00 | $6.9M |

## Frequently Asked Questions

### When did Ovid Therapeutics (OVID) last report earnings?

Ovid Therapeutics last reported on Aug 13, 2025, covering fiscal Q2 2025.

### Did OVID beat earnings estimates?

Yes. Ovid Therapeutics reported EPS of −$0.06 for Q2 2025 against a −$0.16 estimate — a 62.00% beat.

### How much revenue did OVID report last quarter?

Ovid Therapeutics reported $6.3M in revenue for Q2 2025, against a consensus estimate of $98,167.00.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).